日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

ZUMA-1 的五年随访结果支持 axicabtagene ciloleucel 在难治性大 B 细胞淋巴瘤中的治愈潜力

Neelapu, Sattva S; Jacobson, Caron A; Ghobadi, Armin; Miklos, David B; Lekakis, Lazaros J; Oluwole, Olalekan O; Lin, Yi; Braunschweig, Ira; Hill, Brian T; Timmerman, John M; Deol, Abhinav; Reagan, Patrick M; Stiff, Patrick; Flinn, Ian W; Farooq, Umar; Goy, Andre H; McSweeney, Peter A; Munoz, Javier; Siddiqi, Tanya; Chavez, Julio C; Herrera, Alex F; Bartlett, Nancy L; Bot, Adrian A; Shen, Rhine R; Dong, Jinghui; Singh, Kanwarjit; Miao, Harry; Kim, Jenny J; Zheng, Yan; Locke, Frederick L

Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11

Axicabtagene Ciloleucel 与 4-1BB 激动剂 Utomilumab 联合治疗复发/难治性大 B 细胞淋巴瘤患者:ZUMA-11 的 1 期结果

Jain, Michael D; Miklos, David B; Jacobson, Caron A; Timmerman, John M; Sun, Jennifer; Nater, Jenny; Fang, Xiang; Patel, Ankit; Davis, Madison; Heeke, Darren; Trinh, Tan; Mattie, Mike; Neumann, Frank; Kim, Jenny J; To, Christina; Filosto, Simone; Reshef, Ran

89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model

89Zr-ImmunoPET显示抗CD20-IFNα融合蛋白在小鼠B细胞淋巴瘤模型中具有治疗效果

Zettlitz, Kirstin A; Salazar, Felix B; Yamada, Reiko E; Trinh, K Ryan; Vasuthasawat, Alex; Timmerman, John M; Morrison, Sherie L; Wu, Anna M

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma

接受阿西卡巴吉尼西洛莱赛治疗的大B细胞淋巴瘤患者预防性使用皮质类固醇

Oluwole, Olalekan O; Bouabdallah, Krimo; Muñoz, Javier; De Guibert, Sophie; Vose, Julie M; Bartlett, Nancy L; Lin, Yi; Deol, Abhinav; McSweeney, Peter A; Goy, Andre H; Kersten, Marie José; Jacobson, Caron A; Farooq, Umar; Minnema, Monique C; Thieblemont, Catherine; Timmerman, John M; Stiff, Patrick; Avivi, Irit; Tzachanis, Dimitrios; Kim, Jenny J; Bashir, Zahid; McLeroy, Jeff; Zheng, Yan; Rossi, John M; Johnson, Lisa; Goyal, Lovely; van Meerten, Tom

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

KTE-X19 CAR T 细胞疗法治疗复发或难治性套细胞淋巴瘤

Wang, Michael; Munoz, Javier; Goy, Andre; Locke, Frederick L; Jacobson, Caron A; Hill, Brian T; Timmerman, John M; Holmes, Houston; Jaglowski, Samantha; Flinn, Ian W; McSweeney, Peter A; Miklos, David B; Pagel, John M; Kersten, Marie-Jose; Milpied, Noel; Fung, Henry; Topp, Max S; Houot, Roch; Beitinjaneh, Amer; Peng, Weimin; Zheng, Lianqing; Rossi, John M; Jain, Rajul K; Rao, Arati V; Reagan, Patrick M

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

纳武利尤单抗治疗不适合或自体移植失败的复发/难治性弥漫性大B细胞淋巴瘤患者:一项单臂II期研究

Ansell, Stephen M; Minnema, Monique C; Johnson, Peter; Timmerman, John M; Armand, Philippe; Shipp, Margaret A; Rodig, Scott J; Ligon, Azra H; Roemer, Margaretha G M; Reddy, Nishitha; Cohen, Jonathon B; Assouline, Sarit; Poon, Michelle; Sharma, Manish; Kato, Kazunobu; Samakoglu, Selda; Sumbul, Anne; Grigg, Andrew

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

自体造血干细胞移植失败后复发/难治性经典霍奇金淋巴瘤患者接受纳武利尤单抗治疗:多队列单臂 II 期 CheckMate 205 试验的延长随访

Armand, Philippe; Engert, Andreas; Younes, Anas; Fanale, Michelle; Santoro, Armando; Zinzani, Pier Luigi; Timmerman, John M; Collins, Graham P; Ramchandren, Radhakrishnan; Cohen, Jonathon B; De Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trneny, Marek; Shipp, Margaret A; Kato, Kazunobu; Sumbul, Anne; Farsaci, Benedetto; Ansell, Stephen M

ImmunoPET of Malignant and Normal B Cells with (89)Zr- and (124)I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo

利用(89)Zr和(124)I标记的奥妥珠单抗抗体片段对恶性和正常B细胞进行免疫PET成像,揭示了体内CD20内化的差异

Zettlitz, Kirstin A; Tavaré, Richard; Knowles, Scott M; Steward, Kristopher K; Timmerman, John M; Wu, Anna M

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

癌症免疫治疗学会关于免疫疗法治疗血液系统恶性肿瘤(多发性骨髓瘤、淋巴瘤和急性白血病)的共识声明

Boyiadzis, Michael; Bishop, Michael R; Abonour, Rafat; Anderson, Kenneth C; Ansell, Stephen M; Avigan, David; Barbarotta, Lisa; Barrett, Austin John; Van Besien, Koen; Bergsagel, P Leif; Borrello, Ivan; Brody, Joshua; Brufsky, Jill; Cairo, Mitchell; Chari, Ajai; Cohen, Adam; Cortes, Jorge; Forman, Stephen J; Friedberg, Jonathan W; Fuchs, Ephraim J; Gore, Steven D; Jagannath, Sundar; Kahl, Brad S; Kline, Justin; Kochenderfer, James N; Kwak, Larry W; Levy, Ronald; de Lima, Marcos; Litzow, Mark R; Mahindra, Anuj; Miller, Jeffrey; Munshi, Nikhil C; Orlowski, Robert Z; Pagel, John M; Porter, David L; Russell, Stephen J; Schwartz, Karl; Shipp, Margaret A; Siegel, David; Stone, Richard M; Tallman, Martin S; Timmerman, John M; Van Rhee, Frits; Waller, Edmund K; Welsh, Ann; Werner, Michael; Wiernik, Peter H; Dhodapkar, Madhav V

Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection

持续性病毒感染期间Fcγ受体介导的抗体效应功能受到抑制

Yamada, Douglas H; Elsaesser, Heidi; Lux, Anja; Timmerman, John M; Morrison, Sherie L; de la Torre, Juan Carlos; Nimmerjahn, Falk; Brooks, David G